Cardiovascular diseases (CVDs) have become a serious threat to human life and health.
Though many drugs acting via different mechanism of action are available in the market as …

In the field of targeted drug delivery, the effects of size and morphology of drug nanocarriers
are of great importance and need to be discussed in depth. To be concise, among all the …

Atherosclerosis (AS), mainly caused by the changed immune system functions and
inflammation, is the central pathogenesis of cardiovascular disease, which is a leading …

The development of nanomedicines provides new opportunities for the treatment of
atherosclerosis (AS) due to their great advantages such as the improved drug solubility …

Background: Atherosclerotic cardiovascular diseases accounted for a quarter of global
deaths. Most of these fatal diseases like coronary atherosclerotic disease (CAD) and stroke …

Abstract Sexual dissemination of Human Immunodeficiency Virus-1 (HIV-1) is the prime
mode of its spread. Topical microbicidal approach has gained much attention, but no real …

Background. The study was aimed at finding accurate and effective therapeutic targets and
deepening our understanding of the mechanisms of advanced atherosclerosis (AA) …

Cardiovascular complications derivate from atherosclerosis are the main cause of death in
western world. An early detection of vulnerable atherosclerotic plaques is primordial for a …

Recent years have visualized the entry of various new life-threatening diseases in the form
of epidemic and pandemic and hence the introduction of novel drug delivery systems is …

More than 35 million people are living with HIV worldwide with approximately 2.3 million
new infections per year. Cascade of events (cell entry, virus replication, assembly and …